NCCN released updated Genetic/Familial High-Risk Assessment: #Colorectal, #Endometrial, #Gastric #Cancer guidelines on June 13th, including updates to clinical diagnostic criteria for #PeutzJeghersSyndrome among many other important updates. Read more at www.nccn.org/professional...

NCCN just released updated Genetic/Familial High-Risk Assessment: #Breast, #Ovarian, #Pancreatic, & #Prostate #Cancer guidelines today! These new guidelines include updates to #CHEK2, #PALB2, #TP53, & #PTEN content and much more! Check them out at: www.nccn.org/professional...

A new study showed that among men at highest risk of #prostatecancer based on #PRS, more were found to have clinically significant disease (i.e., Gleason 7 or higher) than would have been found with PSA or MRI.
🔗 Learn more at:
www.nejm.org/doi/full/10....

A new study based on work in mice showed that an EZH2 inhibitor (called GSK503) given over 9 weeks in mice lowered the number of #adenomas that formed. Thus, EZH2 might be able to modulate immune-related #genes. Learn more at: pubmed.ncbi.nlm.nih.gov/39946195/

Through #ICARE, we are conducting free #genomic testing on #breast #tumor samples to better understand inherited #breastcancers. Enroll in ICARE using the link below and we will assess your eligibility for this and other focused research efforts
redcap.link/ICAREconsent

Did you know ~80% of #genomics data comes from Europeans, yet they only make up ~16% of the world population? This #bias means important associations for other #ancestry groups may be missed.
Not including #diverse populations in genomics #research can further WIDEN #disparities!